Education
About Us
Working with TipRanks
Follow Us
Hightide Therapeutics Inc (HK:2511)
:2511
2511 Stock Chart & Stats
HK$2.61
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$2.61
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.97 - HK$4.70
Previous CloseN/A
Volume82.00K
Average Volume (3M)1.41M
Market Cap
HK$1.33B
Enterprise ValueHK$852.88M
Total Cash (Recent Filing)HK$467.01M
Total Debt (Recent Filing)HK$99.47M
Price to Earnings (P/E)―
Beta1.41
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding571,325,700
10 Day Avg. Volume641,080
30 Day Avg. Volume1,410,076
Financial Highlights & Ratios
PEG Ratio17.88
Price to Book (P/B)1.27
Price to Sales (P/S)0.00
P/FCF Ratio-1.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hightide Therapeutics Inc News
2511 FAQ
What was Hightide Therapeutics Inc’s price range in the past 12 months?
Hightide Therapeutics Inc lowest stock price was HK$0.97 and its highest was HK$4.70 in the past 12 months.
What is Hightide Therapeutics Inc’s market cap?
Hightide Therapeutics Inc’s market cap is HK$1.33B.
When is Hightide Therapeutics Inc’s upcoming earnings report date?
Hightide Therapeutics Inc’s upcoming earnings report date is Mar 26, 2026 which is in 97 days.
How were Hightide Therapeutics Inc’s earnings last quarter?
Hightide Therapeutics Inc released its earnings results on Aug 25, 2025. The company reported -HK$0.295 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.295.
Is Hightide Therapeutics Inc overvalued?
According to Wall Street analysts Hightide Therapeutics Inc’s price is currently Overvalued.
Does Hightide Therapeutics Inc pay dividends?
Hightide Therapeutics Inc does not currently pay dividends.
What is Hightide Therapeutics Inc’s EPS estimate?
Hightide Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hightide Therapeutics Inc have?
Hightide Therapeutics Inc has 571,325,700 shares outstanding.
What happened to Hightide Therapeutics Inc’s price movement after its last earnings report?
Hightide Therapeutics Inc reported an EPS of -HK$0.295 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.174%.
Which hedge fund is a major shareholder of Hightide Therapeutics Inc?
Currently, no hedge funds are holding shares in HK:2511
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hightide Therapeutics Inc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
273.21%
12-Months-Change
Fundamentals
Return on Equity
-67.27%
Trailing 12-Months
Asset Growth
-13.34%
Trailing 12-Months
Company Description
Hightide Therapeutics Inc
Hightide Therapeutics Inc (2511) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of metabolic and digestive diseases. The company leverages its expertise in drug development to address unmet medical needs and improve patient outcomes. Hightide Therapeutics is committed to advancing its pipeline of proprietary compounds and fostering collaborations to bring novel treatments to market.
Technical Analysis
Brii Biosciences Limited
―
Genor Biopharma Holdings Limited
―
TOT BIOPHARM International Co. Ltd.
―
JW (Cayman) Therapeutics Co. Ltd.
―
Mabpharm Limited
―
Options Prices
Currently, No data available
---